STANDEX TO PARTICIPATE IN D.A. DAVIDSON BEST-OF-BREED BISON CONFERENCE
STANDEX TO PARTICIPATE IN D.A. DAVIDSON BEST-OF-BREED BISON CONFERENCE
PR Newswire
SALEM, N.H., March 5, 2024
SALEM, N.H., March 5, 2024 /PRNewswire/ -- Standex International Corporation (NYSE: SXI) announced today that David Dunbar, President & CEO, and Ademir Sarcevic, CFO, will be participating in the D.A. Davidson Best-of-Breed Bison Conference on Friday, March 8, 2024.
Interested parties may access the Company's presentation on the Investor Relations section of Standex's website under the subheading, Events and Presentations, located on the Company's website standex.com.
About Standex
Standex International Corporation is a multi-industry manufacturer in five broad business segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, South Africa, India, and China. For additional information, visit the Company's website at http://standex.com/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-to-participate-in-da-davidson-best-of-breed-bison-conference-302079833.html
SOURCE Standex International Corporation
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track